Barclays Lowers Adient (ADNT) Price Target to $69.00
Several other research firms have also weighed in on ADNT. Guggenheim set a $64.00 price target on shares of Adient and gave the company a hold rating in a research report on Tuesday. Robert W. Baird reduced their price target on shares of Adient from $81.00 to $73.00 and set a neutral rating for the company in a research report on Tuesday. UBS Group reduced their price target on shares of Adient from $96.00 to $92.00 and set a buy rating for the company in a research report on Thursday, January 25th. JPMorgan Chase & Co. lowered shares of Adient from a neutral rating to an underweight rating and reduced their price target for the company from $86.00 to $74.00 in a research report on Monday, January 22nd. Finally, Zacks Investment Research upgraded shares of Adient from a hold rating to a buy rating and set a $94.00 price target for the company in a research report on Monday, October 2nd. Three research analysts have rated the stock with a sell rating, six have issued a hold rating and four have assigned a buy rating to the company’s stock. Adient presently has a consensus rating of Hold and an average price target of $72.09.
Adient (ADNT) opened at $64.60 on Tuesday. The firm has a market cap of $6,020.00 and a PE ratio of 11.88. The company has a current ratio of 1.02, a quick ratio of 0.87 and a debt-to-equity ratio of 0.78. Adient has a 1 year low of $59.10 and a 1 year high of $86.42.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, February 15th. Shareholders of record on Thursday, January 18th will be given a dividend of $0.275 per share. The ex-dividend date is Wednesday, January 17th. This represents a $1.10 dividend on an annualized basis and a yield of 1.70%. Adient’s dividend payout ratio is presently 20.22%.
In other news, VP Cathleen A. Ebacher sold 2,584 shares of the firm’s stock in a transaction that occurred on Monday, December 4th. The shares were sold at an average price of $79.13, for a total value of $204,471.92. Following the completion of the transaction, the vice president now directly owns 36,454 shares in the company, valued at $2,884,605.02. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Cathleen A. Ebacher sold 9,184 shares of the firm’s stock in a transaction that occurred on Tuesday, November 28th. The shares were sold at an average price of $78.40, for a total transaction of $720,025.60. Following the completion of the transaction, the vice president now owns 38,187 shares of the company’s stock, valued at $2,993,860.80. The disclosure for this sale can be found here. Insiders have sold 79,525 shares of company stock valued at $6,242,744 in the last quarter. Company insiders own 0.14% of the company’s stock.
Adient Company Profile
Adient plc, formerly Adient Limited, is an automotive seating supplier. The Company designs, manufactures and markets a range of seating systems and components for passenger cars, commercial vehicles, and light trucks, including vans, pick-up trucks, and sport/crossover utility vehicles. The Company operates through two segments: Seating and Interiors.
Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.